ILLUMINA acquires SomaLogic
ILLUMINA agreed to acquire SomaLogic. Reported deal value: $425M. Status: Announced. Sector: Proteomics. Target headquarters context: Boulder, Colorado, United States.
This page summarizes publicly available information about the transaction as of 2026-02-21. Figures and status may change as filings and press coverage update.
Last updated Feb 22, 202 6 Key Stats for Illumina Stock Past-Week Performance: 2% 52-Week Range: $69 to $ 15 6 Current Price: $118 What Happened to Illumina Stock? Illumina ( ILMN ) shares closed at $117.67 yesterday, though the stock had surged as high as $ 15 1 in mid-January when the company simultaneously previewed a Q4 revenue beat , announced the Billion Cell Atlas with AstraZeneca, Merck, and Eli Lilly, and completed the $350 million SomaLogic acquisition within the same three-week window
Deal timeline
This transaction is classified in Proteomics with a reported deal value of $425M. Figures and status may change as sources update.